Landscapes / Targets

IDH1

9 drugs act on IDH1, in 24 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs9

DrugHow it worksCompanyStageNext dateDetails
—
Rigel Pharmaceuticals +1
Approved 30 Apr 2027Phase 4 trial completes
Isocitrate dehydrogenase 1 inhibitor
Approved 15 Oct 2027Phase 3 trial completes
Isocitrate dehydrogenase 1 Inhibitor; isocitrate dehydrogenase 2 inhibitor
Approved 2 May 2033Phase 2 trial completes
—
Phase 3 Dec 2026Phase 3 trial completes
—
Phase 3 1 Dec 2028Phase 3 trial completes
—
Phase 3 31 Dec 2028Phase 3 trial completes
Olutasidenibnot checked
—
Phase 2 Sep 2030Phase 2 trial completes
—
Novartis · Public NVS
Phase 1 —
—
Eli Lilly · Public LLY
Phase 1 —

About this list

Checked
8 of 9 drugs. The other 1 is marked “not checked” in the list. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow IDH1

Following is part of Solo: you see every change to IDH1 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in